{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "11167031", "DateCompleted": {"Year": "2001", "Month": "04", "Day": "26"}, "DateRevised": {"Year": "2022", "Month": "03", "Day": "18"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": [], "Journal": {"ISSN": "0378-8741", "JournalIssue": {"Volume": "74", "Issue": "2", "PubDate": {"Year": "2001", "Month": "Feb"}}, "Title": "Journal of ethnopharmacology", "ISOAbbreviation": "J Ethnopharmacol"}, "ArticleTitle": "Inhibitory action of water soluble fraction of Terminalia chebula on systemic and local anaphylaxis.", "Pagination": {"StartPage": "133", "EndPage": "140", "MedlinePgn": "133-40"}, "Abstract": {"AbstractText": ["We investigated the effects of the water soluble fraction of Terminalia chebula (Combretaceae) (WFTC) on systemic and local anaphylaxis. WFTC administered 1h before compound 48/80 injection inhibited compound 48/80-induced anaphylactic shock 100% with doses of 0.01-1.0 g/kg. When WFTC was administered 5 or 10 min after compound 48/80 injection, the mortality also decreased in a dose-dependent manner. Passive cutaneous anaphylaxis was inhibited by 63.5+/-7.8% by oral administration of WFTC (1.0 g/kg). When WFTC was pretreated at concentrations ranging from 0.005 to 1.0 g/kg, the serum histamine levels were reduced in a dose-dependent manner. WFTC (0.01-1.0 mg/ml) also significantly inhibited histamine release from rat peritoneal mast cells (RPMC) by compound 48/80. However, WFTC (1.0 mg/ml) had a significant increasing effect on anti-dinitrophenyl IgE-induced tumor necrosis factor-alpha production from RPMC. These results indicate that WFTC may possess a strong antianaphylactic action."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Pharmacy, Woosuk University, Chonju, 565-701, Chonbuk, South Korea."}], "Identifier": [], "LastName": "Shin", "ForeName": "T Y", "Initials": "TY"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Jeong", "ForeName": "H J", "Initials": "HJ"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Kim", "ForeName": "D K", "Initials": "DK"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Kim", "ForeName": "S H", "Initials": "SH"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Lee", "ForeName": "J K", "Initials": "JK"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Kim", "ForeName": "D K", "Initials": "DK"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Chae", "ForeName": "B S", "Initials": "BS"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Kim", "ForeName": "J H", "Initials": "JH"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Kang", "ForeName": "H W", "Initials": "HW"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Lee", "ForeName": "C M", "Initials": "CM"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Lee", "ForeName": "K C", "Initials": "KC"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Park", "ForeName": "S T", "Initials": "ST"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Lee", "ForeName": "E J", "Initials": "EJ"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Lim", "ForeName": "J P", "Initials": "JP"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Kim", "ForeName": "H M", "Initials": "HM"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Lee", "ForeName": "Y M", "Initials": "YM"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "Ireland", "MedlineTA": "J Ethnopharmacol", "NlmUniqueID": "7903310", "ISSNLinking": "0378-8741"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Dinitrophenols"}, {"RegistryNumber": "0", "NameOfSubstance": "Indicators and Reagents"}, {"RegistryNumber": "0", "NameOfSubstance": "Tumor Necrosis Factor-alpha"}, {"RegistryNumber": "37341-29-0", "NameOfSubstance": "Immunoglobulin E"}, {"RegistryNumber": "4091-50-3", "NameOfSubstance": "p-Methoxy-N-methylphenethylamine"}, {"RegistryNumber": "820484N8I3", "NameOfSubstance": "Histamine"}], "MeshHeadingList": [{"QualifierName": ["drug therapy"], "DescriptorName": "Anaphylaxis"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["antagonists & inhibitors"], "DescriptorName": "Dinitrophenols"}, {"QualifierName": ["blood"], "DescriptorName": "Histamine"}, {"QualifierName": ["drug effects"], "DescriptorName": "Histamine Release"}, {"QualifierName": ["immunology"], "DescriptorName": "Immunoglobulin E"}, {"QualifierName": [], "DescriptorName": "Indicators and Reagents"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "Mast Cells"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Mice, Inbred ICR"}, {"QualifierName": ["drug effects"], "DescriptorName": "Passive Cutaneous Anaphylaxis"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": [], "DescriptorName": "Rats, Sprague-Dawley"}, {"QualifierName": ["biosynthesis"], "DescriptorName": "Tumor Necrosis Factor-alpha"}, {"QualifierName": ["pharmacology"], "DescriptorName": "p-Methoxy-N-methylphenethylamine"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2001", "Month": "2", "Day": "13", "Hour": "11", "Minute": "0"}, {"Year": "2001", "Month": "5", "Day": "1", "Hour": "10", "Minute": "1"}, {"Year": "2001", "Month": "2", "Day": "13", "Hour": "11", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["11167031", "10.1016/s0378-8741(00)00360-3", "S0378-8741(00)00360-3"]}}], "PubmedBookArticle": []}